Dmpa-sc - Open Access .click

Results 111 to 120 of about 607 (121)

Some of the next articles are maybe not open access.

Effect of subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women

Contraception, 2012
The effects of subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) injection on androgenic markers in obese women have not previously been studied.Five normal-weight [body mass index (BMI)=18.5-24.9 kg/m²], five obese (BMI=30-39.9 kg/m²) and five extremely obese (BMI≥40 kg/m²) women were recruited for this prospective experimental study in which ...
Penina, Segall-Gutierrez +6 more
openaire +2 more sources

National Policy Landscape Analysis on DMPA-SC: Pakistan Final Report

2023
Azmat, Syed Khurram, Awan, Muhammad Ali
openaire +1 more source

Subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) use in obese and morbidly obese women: incidence of ovulation and follicular development

2015
Background: Subcutaneous depo-medroxyprogesterone acetate (DMPA-SC) has not been studied in the morbidly obese population. The purpose of this 26-week prospective experimental study is to determine incidence of ovulation and follicular development among obese and morbidly obese women after DMPA-SC.
openaire +1 more source

Science Says: Self-administered DMPA-SC is safe, feasible, and acceptable

2023
openaire +1 more source

DMPA-IM, DMPA-SC: Side Effect Differences Few

Pediatric News, 2010
openaire +1 more source

PERSPECTIVES TOWARD DMPA-SC SELF-ADMINISTRATION AMONG BLACK WOMEN

Contraception
F Lawal, K LaRoche, R Hubach
openaire +1 more source

Investigational DMPA-SC Treats Endometriosis Pain, Curbs BMD Loss

Ob.Gyn. News, 2005
openaire +1 more source

DMPA SC dataset

2019
openaire +1 more source

Few Side Effect Differences Between DMPA-IM, DMPA-SC

Family Practice News, 2010
openaire +1 more source